Founded in 2001 as a software services provider, TAKE is currently a technology driven, full service Clinical Research Organization. It helps biopharma companies throughout the drug development process, and beyond. Headquartered in Chennai, India, it has a global footprint spanning the Americas, Europe and the Asia Pacific region.
The co. delivers domain-intensive services in Life Sciences. TAKE is the only full-service technology-driven Clinical Research Organization listed in India. It has 1,70,000 regulatory submissions and submitted 5% of all regulatory submissions to USFDA 2012 to 2020.
Take Solutions Ltd reported Revenues for Q1FY24 of ₹17.46 Crores down from ₹57.48 Crore year on year, a fall of 69.62%.
Total Expenses for Q1FY24 of ₹22.45 Crores down from ₹66.91 Crores year on year, a fall of 66.45%.
Consolidated Net Profit of -₹5.32 Crores from -₹26.35 Crores in the same quarter of the previous year.
The Earnings per Share is -₹0.36, from -₹1.77 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,